B-Cell Receptor CD22 / SIGLEC2 (CD22) Antibody (FITC)

Este producto es parte de CD22 - CD22 molecule
Product Graph
429€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
B-Cell Receptor CD22 / SIGLEC2 (CD22) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx413807
tested applications
FCM

Description

B-cell Receptor CD22 (CD22) Antibody (FITC) is a Rat Monoclonal antibody against B-cell Receptor CD22 (CD22).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetB-Cell Receptor CD22 / SIGLEC2 (CD22)
HostRat
ReactivityMouse
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConjugationFITC
IsotypeIgG1
PurificationPurified
Size 1100 µg
FormLiquid
Tested ApplicationsFCM
BufferPBS, 1% BSA. Contains sodium azide.
AvailabilityShipped within 3-7 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP35329
AliasSIGLEC2,SIGLEC-2,B-cell receptor CD22,B-lymphocyte cell adhesion molecule,BL-CAM,Sialic acid-binding Ig-like lectin 2,T-cell surface antigen Leu-14
BackgroundAntibody anti-CD22
StatusRUO
NoteConcentration: 0.1 mg/ml -

Descripción

CD22, also known as Siglec-2, is a member of the sialic acid-binding immunoglobulin-like lectins (Siglec) family and is predominantly expressed on B cells. It plays a crucial role in modulating B-cell receptor (BCR) signaling and maintaining B-cell tolerance, making it an essential molecule in the regulation of the immune system. CD22 is primarily found on mature B cells, acting both as an inhibitory coreceptor to dampen BCR signaling and as an adhesion molecule involved in cell-cell interactions. CD22 is essential for maintaining the delicate balance between immune activation and tolerance, preventing excessive immune responses that could lead to autoimmune diseases. It is an inhibitory receptor that modulates B-cell activity by recruiting SHP-1, a phosphatase that negatively regulates B-cell signaling pathways. In this capacity, CD22 fine-tunes the immune response to antigens, ensuring that B cells are appropriately activated and preventing autoimmunity.

Related Products

EH3781

Human SIGLEC2(Sialic Acid Binding Ig Like Lectin 2) ELISA Kit

Ver Producto
FNab01444

anti- CD22 antibody

Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules.

Ver Producto
FNab10004

anti- CD22 antibody

Ver Producto